Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Anika Therapeutics, Inc. (ANIK) is a Medical - Devices company based in US with a market capitalization of $196.4M. Revenue declined 5.9% year-over-year and the company generated $4.4M in free cash flow. This page tracks ANIK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 288 employees · IPO May 3, 1993
Valuation
Valuation & price
$14.91 · as of May 17, 2026 · -6.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.37
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$196.4M
Market cap
-5.9%
Revenue growth (YoY)
56.6%
Gross margin
$4.4M
Free cash flow (USD)
-$33.3M
Net debt
Net cash position
-2.6%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
2
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed Apr 30, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventIncentive Plan EstablishedJun 23, 2026Filing
- Insider buyInsider Buy $73KHENNEMAN JOHN B III · Director · $73.3KMay 4, 2026Filing
- Insider buyInsider Buy $150KGriffin Stephen D. · Director, President and CEO · $149.9KApr 30, 2026Filing
- Quarterly report10-Q FiledApr 30, 2026Filing
- 8-K eventEarnings ReleaseApr 29, 2026Filing
Questions
Frequently asked questions
What is Anika Therapeutics, Inc.'s market cap?
Anika Therapeutics, Inc. (ANIK) has a market capitalization of $196.4M.
What is ANIK's P/E ratio?
A meaningful P/E ratio is not available for ANIK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ANIK's price-to-book (P/B) ratio?
ANIK trades at 1.37 times book value per share.
Are insiders buying ANIK stock?
Yes — SEC Form 4 filings show 2 open-market insider buys and 0 sells at Anika Therapeutics, Inc. in the last 90 days.
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.